Skip to main content
Premium Trial:

Request an Annual Quote

Hoffmann-La Roche Buys DeCypher Accelerator For Drug Discovery

Premium

INCLINE VILLAGE, Nev.--Time Logic here has sold a DeCypher ES-1920 computational bioinformatics accelerator to Hoffmann-La Roche, which "intends to use this powerful computer tool in the process of the discovery of new drugs to treat human diseases and conditions," according to the pharmaceutical company's Michael Braxenthaler. DeCypher uses unique search algorithms, accelerated to supercomputing speeds by an array of parallel processors, to rapidly search large DNA and protein sequence databases, according to Richard Offerdahl, the company's president and CEO.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.